Pacific Biosciences of California Inc. (PACB) Declined -5.32% or -0.14 To Price $2.4 On Tuesday

Pacific Biosciences of California Inc. (PACB) declined -5.32% or -0.14 to $2.4. It is approximately 1.29 million shares traded, which is 98.73% compare to the average total volume 1.31 million. The market cap of PACB is $279.65 million. The year to date change is -8.96%. The 52 week price range is from $2.25 to $5.74. Price of PACB have changed -2.31% during last week. It have changed -6.62% over last month, -11.81% over last 3 months, -41.47% over last 6 months and -50.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PACB is 2.75. It is 14.58% above current price. The 200-day Moving Averages for PACB is 3.69. It is 53.75% above current price. The 52-week High is 5.74. It is 139.17% from the current price. The 52-week Low is 2.25. It is -6.25% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PACB is 7.85 on 2018-01-31. Short % to float is 9.76%. There are some statistics of PACB. It is has market cap $279.65 million. The share outstanding is 116.28 million. The average volume is 1.31 million. The revenue is 93.47M. It has 305.48M cash and 42.87M in debt. The gross profit is 34.66M. The percent of top 15 Institution holding is 69.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PACB is -107.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PACB is -65.39%.


Share this post